Building the evidence base for current systemic treatments for severe, chronic atopic dermatitis: methotrexate vs. azathioprine
- PMID: 29897127
- DOI: 10.1111/bjd.16594
Building the evidence base for current systemic treatments for severe, chronic atopic dermatitis: methotrexate vs. azathioprine
Comment on
-
Methotrexate and azathioprine for severe atopic dermatitis: a 5-year follow-up study of a randomized controlled trial.Br J Dermatol. 2018 Jun;178(6):1288-1296. doi: 10.1111/bjd.16240. Epub 2018 Apr 10. Br J Dermatol. 2018. PMID: 29237228 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources